HPTN

About

Business profile

HPTN | The HIV Prevention Trials Network Skip to main content WEBINAR: Leveraging Implementation Science for HIV Prevention – Thursday, 13 August at 10am ET Main navigation Menu About About Research Agenda Leadership Committees Operations Funding Acknowledgements Our Research Studies Sites Publications Public Data Sets Presented Research Submit a Research Idea HPTN Scholars Program Community Community Engagement Program Resources Manual of Procedures Communications & Brand Guide Research Proposals Research Resources Manuscript Review News & Events HPTN Annual Meeting Events Announcements Press Releases Newsletters Contact Key Contacts Directory Email Lists Homepage Research toward a future without HIV. Quick Links Directory Studies MOP Our Mission The HPTN develops and evaluates cutting-edge biomedical, behavioral, and structural interventions to reduce the transmission of HIV. Who We Are Research Proposals Community Program Scholars Program Innovative, transformative, and impactful 25 Active Studies 55 Study Sites 13 Countries 587 Publications Our Research Agenda The HPTN research agenda focuses on four strategies: Long-acting antiretroviral (ARV) agents for pre-exposure prophylaxis (PrEP) Multipurpose prevention technologies (MPTs) Broadly neutralizing antibodies (bnAbs) Integrated strategies for HIV prevention Learn More Powered by Collaboration We are the HPTN The HPTN is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community members, and other partners in the advancement of HIV prevention.

Services

What this business offers

Agentic gateway

Declared AI capabilities